This brand name is authorized in Japan
The drug GONALEF contains one active pharmaceutical ingredient (API):
|
1
Follitropin alfa
UNII VV3HN9ZPB5 - FOLLITROPIN ALFA
|
|
In women, the most important effect resulting from parenteral administration of FSH is the development of mature Graafian follicles. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| G03GA05 | Follitropin alfa | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2413404D1025, 2413404D2021, 2413404G1021, 2413404G2028, 2413404G3024 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
